Literature DB >> 20074574

Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study.

Rocco Maurizio Zagari1, Graham Richard Law, Lorenzo Fuccio, Vincenzo Cennamo, Mark S Gilthorpe, David Forman, Franco Bazzoli.   

Abstract

BACKGROUND & AIMS: Population-based endoscopic studies are needed to assess the epidemiology of functional dyspepsia (FD) and the newly suggested subgroups of meal-related symptoms and epigastric pain. We evaluated the prevalence of, and risk factors for, FD in the Italian general population.
METHODS: A total of 1533 inhabitants of 2 villages were invited to undergo symptom evaluation using a validated questionnaire, esophagogastroduodenoscopy, and (13)C-urea breath test; 1033 subjects (67.4%) took part.
RESULTS: Of the 1033 subjects, 156 (15.1%; 95% confidence interval [CI], 12.9-17.3) had dyspepsia, and of these 114 (11%; 95% CI, 9.2-12.9) had FD. Of the 114 subjects with FD, 77 (67.5%) had meal-related symptoms (postprandial fullness and/or early satiation) and 55 (48.2%) had epigastric pain. Only 18 subjects (15.8%) had both meal-related symptoms and epigastric pain; this was fewer than expected by chance alone (P < .001). Unemployment (odds ratio [OR], 5.80; 95% CI, 1.56-21.60), divorce (OR, 2.76; 95% CI, 1.10-6.91), smoking (OR, 1.74; 95% CI, 1.11-2.70), and irritable bowel syndrome (OR, 3.38; 95% CI, 1.85-6.19) were significantly associated with FD. Unemployment, divorce, and irritable bowel syndrome were associated with both meal-related symptoms and epigastric pain, while smoking was associated only with meal-related symptoms.
CONCLUSIONS: FD is present in 11% of the Italian general population. Unemployment and divorce seem to increase the risk of FD, and smoking seems to be associated with meal-related symptoms. Two distinct subgroups of FD, as suggested by Rome III, seem to exist in the general population. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20074574     DOI: 10.1053/j.gastro.2009.12.057

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Women and functional dyspepsia.

Authors:  Kate Napthali; Natasha Koloski; Marjorie M Walker; Nicholas J Talley
Journal:  Womens Health (Lond)       Date:  2016-02-22

2.  Offshore training in navy personnel is associated with uninvestigated dyspepsia.

Authors:  Fan Li; Gang Sun; Yun-Sheng Yang; Li-Hong Cui; Li-Hua Peng; Xu Guo; Wei-Feng Wang; Bin Yan; Lanjing Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

3.  Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria.

Authors:  Byung-Hoon Min; Kyu Chan Huh; Hye-Kyung Jung; Young Hoon Yoon; Kee Don Choi; Kyung Ho Song; Bora Keum; Jung Won Kim
Journal:  Dig Dis Sci       Date:  2014-06-13       Impact factor: 3.199

4.  Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

Authors:  Yao-Chun Hsu; Jyh-Ming Liou; Tzeng-Huey Yang; Wei-Lun Hsu; Hwai-Jeng Lin; Huei-Tang Wu; Jaw-Town Lin; Hsiu-Po Wang; Ming-Shiang Wu
Journal:  J Gastroenterol       Date:  2010-10-19       Impact factor: 7.527

5.  Simotang enhances gastrointestinal motility, motilin and cholecystokinin expression in chronically stressed mice.

Authors:  Guang-Xian Cai; Bai-Yan Liu; Jian Yi; Xue-Mei Chen; Fu-Ling Liu
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

6.  Epidemiology of Dyspepsia and Irritable Bowel Syndrome (IBS) in Medical Students of Northern India.

Authors:  Sumeena Basandra; Divyansh Bajaj
Journal:  J Clin Diagn Res       Date:  2014-12-05

7.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 8.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

Review 9.  Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.

Authors:  Jan Tack; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

10.  Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.

Authors:  H Vanheel; F Carbone; L Valvekens; M Simren; H Tornblom; T Vanuytsel; L Van Oudenhove; J Tack
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.